The performance of companies tied to iconic drugs like Viagra presents a nuanced investment scenario . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key regions has introduced considerable uncertainty . Investors are now assessing the consequences of gen